AFFINITY WEALTH LLC’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.69K Hold
64
﹤0.01% 21
2026
Q1
$3.88K Hold
64
﹤0.01% 19
2025
Q4
$3.45K Sell
64
-335
-84% -$16.1K ﹤0.01% 45
2025
Q3
$18K Hold
399
0.01% 28
2025
Q2
$18.5K Hold
399
0.02% 27
2025
Q1
$24.3K Buy
399
+9
+2% +$525 0.02% 18
2024
Q4
$22.1K Buy
+390
New +$21.8K 0.02% 17

Other funds holding BMY

AFFINITY WEALTH LLC's BMY Position: Q2 2026 in Review

AFFINITY WEALTH LLC held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 64 shares worth $3.69K. The position accounts for ﹤0.01% of the portfolio, ranked #21.

AFFINITY WEALTH LLC first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $24.3K in Q1 2025. 2,513 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • AFFINITY WEALTH LLC held 64 shares of Bristol-Myers Squibb worth $3.69K as of Q2 2026.
  • AFFINITY WEALTH LLC left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of AFFINITY WEALTH LLC's portfolio in Q2 2026, its #21 holding.
  • AFFINITY WEALTH LLC first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • AFFINITY WEALTH LLC's Bristol-Myers Squibb position peaked at $24.3K in Q1 2025.
  • 2,513 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on AFFINITY WEALTH LLC's 13F filing for Q2 2026, filed 26 Aug 2026.